PubMed

Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.

Evans DW, Hosking SL, Gherghel D, Bartlett JD.

Br J Ophthalmol. 2003 Dec;87(12):1463-5.PMID: 14660453 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.

Schuman JS.

Ophthalmology. 2000 Jun;107(6):1171-7.PMID: 10857839 [PubMed - indexed for MEDLINE]Related articles

The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.

Yüksel N, Altintaş O, Karabaş L, Alp B, Cağlar Y.

Ophthalmologica. 1999;213(4):228-33.PMID: 10420106 [PubMed - indexed for MEDLINE]Related articles

A short term study of the additive effect of timolol and brimonidine on intraocular pressure.

Arici MK, Sayici M, Toker M, Erdoğan H, Topalkara A.

Eye (Lond). 2002 Jan;16(1):39-43.PMID: 11913886 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.

Thelen U, Buchholz P, Kimmich F.

Curr Med Res Opin. 2009 Apr;25(4):1003-9.PMID: 19275517 [PubMed - indexed for MEDLINE]Related articles

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.

Konstas AG, Stewart WC, Topouzis F, Tersis I, Holmes KT, Stangos NT.

Am J Ophthalmol. 2001 Jun;131(6):729-33.PMID: 11384568 [PubMed - indexed for MEDLINE]Related articles

A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.

Clin Ther. 2006 Apr;28(4):552-9.PMID: 16750466 [PubMed - indexed for MEDLINE]Related articles

Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study.

Vetrugno M, Maino A, Cantatore F, Ruggeri G, Cardia L.

Clin Ther. 2001 Sep;23(9):1519-28.PMID: 11589264 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.

Oztürk F, Ermiş SS, Inan UU, Aşagidag A, Yaman S.

J Ocul Pharmacol Ther. 2005 Feb;21(1):68-74.PMID: 15718830 [PubMed - indexed for MEDLINE]Related articles

Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma.

Evans DW, Bartlett JD, Houde B, Than TP, Shaikh A.

J Ocul Pharmacol Ther. 2008 Apr;24(2):224-9.PMID: 18355134 [PubMed - indexed for MEDLINE]Related articles

Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.

Craven ER, Walters TR, Williams R, Chou C, Cheetham JK, Schiffman R; Combigan Study Group.

J Ocul Pharmacol Ther. 2005 Aug;21(4):337-48.PMID: 16117698 [PubMed - indexed for MEDLINE]Related articles

Systemic beta-blocker therapy and brimonidine and timolol.

Coulibaly R.

Ophthalmology. 2001 Aug;108(8):1368. No abstract available. PMID: 11470677 [PubMed - indexed for MEDLINE]Related articles

Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients.

Arend O, Harris A, Wolter P, Remky A.

Acta Ophthalmol Scand. 2003 Oct;81(5):474-9.PMID: 14510794 [PubMed - indexed for MEDLINE]Related articles

Effects of brimonidine 0.2% on blue-yellow perimetry of glaucomatous patients.

Mastropasqua L, Ciancaglini M, Carpineto P, Zuppardi E, Falconio G, Gallenga PE.

Acta Ophthalmol Scand Suppl. 1998;(227):36.PMID: 9972338 [PubMed - indexed for MEDLINE]Related articles

Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension.

Lee DA.

Clin Ther. 2000 Jan;22(1):53-65.PMID: 10688390 [PubMed - indexed for MEDLINE]Related articles

A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.

Yüksel N, Karabaş L, Altintaş O, Yildirim Y, Cağlar Y.

Ophthalmologica. 2002 Jan-Feb;216(1):45-9.PMID: 11901288 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study.

Tsai JC, Chang HW.

J Ocul Pharmacol Ther. 2005 Dec;21(6):475-82.PMID: 16386089 [PubMed - indexed for MEDLINE]Related articles

Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.

Feldman RM, Tanna AP, Gross RL, Chuang AZ, Baker L, Reynolds A, Prager TC; Additivity Study Group.

Ophthalmology. 2007 Jul;114(7):1248-54. Epub 2007 May 23.PMID: 17509688 [PubMed - indexed for MEDLINE]Related articles

A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.

Siesky B, Harris A, Sines D, Rechtman E, Malinovsky VE, McCranor L, Yung CW, Zalish M.

J Ocul Pharmacol Ther. 2006 Oct;22(5):353-61.PMID: 17076630 [PubMed - indexed for MEDLINE]Related articles

The role of brimonidine in the treatment of open-angle glaucoma.

Wilensky JT.

Surv Ophthalmol. 1996 Nov;41 Suppl 1:S3-7. Review.PMID: 8970244 [PubMed - indexed for MEDLINE]Related articles